COVID-19 vaccine Archive — Page 3 of 4

Amya Elliott, 9, talks with Bonnie Pilon, RN, prior to receiving her COVID-19 vaccination at Monroe Carell Jr. Children’s Hospital at Vanderbilt. The hospital began mass vaccination for children ages 5-11 on Monday, Nov. 8.
November 11, 2021

Vaccination day at Children’s Hospital

Monroe Carell Jr. Children’s Hospital at Vanderbilt began mass vaccination for children ages 5-11 on Monday, Nov. 8.

By Vanderbilt Health News
Masked healthcare worker in blue scrubs administers a vaccine injection to a masked woman’s upper arm inside a vaccination tent; numbered signs 5 and 6 are visible overhead.
October 7, 2021

Boosta-Palooza

VUMC employees were able to receive a single booster dose of the Pfizer COVID-19 vaccine at this week’s Boosta-Palooza event.

By Vanderbilt Health News
Portrait of Jeff Balser, MD, PhD, wearing glasses, a dark suit, white shirt, and patterned tie.
September 22, 2021

Rounds: Hard conversations

By Doug Campbell
Tesha Akins
August 10, 2021

Shared antibodies may push COVID-19 variants: VUMC study

Researchers at Vanderbilt University Medical Center have found that people recovering from COVID-19 and those vaccinated against the causative virus, SARS-CoV-2, produce identical clones, or groups, of antibody-producing white blood cells.

By Bill Snyder
Jeff Balser, MD, PhD, discusses VUMC’s top priorities during this week’s Leadership Assembly.
August 5, 2021

Digital growth, improvements, vaccinations: Leadership Assembly takeaways

Vanderbilt University Medical Center completed its first full fiscal year of the COVID-19 era having achieved remarkable outcomes in digital health, growth and quality because of consistently strong performance from its workforce.

By Holly Fletcher
Professional head-and-shoulders portrait of Elizabeth Phillips, MD, wearing a gray blazer and pearl necklace against a softly blurred brown backdrop.
July 27, 2021

Using Patients’ Allergy History as Screening Tool for mRNA COVID-19 Vaccine Works Well: Study

A report of more than 23,000 health care workers and employees at Vanderbilt University Medical Center who received the Pfizer-BioNTech mRNA COVID-19 vaccine shows that a risk stratification screening mechanism for potential allergies to the vaccine worked exceedingly well as the vaccine program rolled out in December 2020.

By Nancy Humphrey